Lam Research Co. (NASDAQ:LRCX) Shares Sold by Horizon Family Wealth Inc.

Horizon Family Wealth Inc. decreased its position in shares of Lam Research Co. (NASDAQ:LRCXFree Report) by 3.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 408 shares of the semiconductor company’s stock after selling 14 shares during the quarter. Horizon Family Wealth Inc.’s holdings in Lam Research were worth $320,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of LRCX. Orion Capital Management LLC purchased a new stake in shares of Lam Research in the third quarter worth about $25,000. OFI Invest Asset Management acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $30,000. Asset Dedication LLC grew its stake in shares of Lam Research by 56.7% during the 3rd quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock worth $30,000 after purchasing an additional 17 shares during the period. Valued Wealth Advisors LLC acquired a new position in shares of Lam Research in the 4th quarter valued at $30,000. Finally, SouthState Corp lifted its stake in shares of Lam Research by 54.5% in the 3rd quarter. SouthState Corp now owns 51 shares of the semiconductor company’s stock valued at $32,000 after purchasing an additional 18 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Stock Performance

Shares of LRCX traded up $35.21 during midday trading on Wednesday, hitting $947.75. 713,286 shares of the stock traded hands, compared to its average volume of 1,030,671. The business’s 50 day moving average price is $936.10 and its two-hundred day moving average price is $835.98. Lam Research Co. has a 1-year low of $549.29 and a 1-year high of $1,007.39. The firm has a market capitalization of $123.91 billion, a PE ratio of 34.44, a price-to-earnings-growth ratio of 2.80 and a beta of 1.51. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.84 and a current ratio of 2.82.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 EPS for the quarter, topping the consensus estimate of $7.26 by $0.53. The firm had revenue of $3.79 billion for the quarter, compared to analysts’ expectations of $3.72 billion. Lam Research had a net margin of 25.35% and a return on equity of 45.96%. During the same period in the previous year, the business earned $6.99 earnings per share. Lam Research’s revenue for the quarter was down 2.0% compared to the same quarter last year. Equities research analysts predict that Lam Research Co. will post 29.66 EPS for the current fiscal year.

Insider Activity at Lam Research

In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the transaction, the director now owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Abhijit Y. Talwalkar sold 882 shares of Lam Research stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the transaction, the director now directly owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now directly owns 22,095 shares in the company, valued at approximately $20,380,648.95. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,489 shares of company stock valued at $6,978,065. 0.32% of the stock is owned by corporate insiders.

Analyst Ratings Changes

LRCX has been the subject of a number of recent analyst reports. Citigroup lifted their price objective on shares of Lam Research from $975.00 to $1,025.00 and gave the company a “buy” rating in a report on Thursday, April 25th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $1,100.00 price target on shares of Lam Research in a report on Thursday, April 25th. Susquehanna dropped their price objective on Lam Research from $880.00 to $850.00 and set a “neutral” rating on the stock in a report on Thursday, April 25th. B. Riley upgraded Lam Research from a “neutral” rating to a “buy” rating and increased their target price for the company from $870.00 to $1,100.00 in a research report on Friday, April 19th. Finally, Stifel Nicolaus increased their price objective on shares of Lam Research from $950.00 to $1,050.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Seven investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $957.95.

Check Out Our Latest Research Report on LRCX

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.